Peptide-Modified Nanoparticles for Tumor Targeting and Molecular Imaging

Author(s): Liejing Lu, Qinyuan Zhang, Zhe Wang, Liqian Gao*, Jun Shen*

Journal Name: Current Medicinal Chemistry

Volume 28 , Issue 31 , 2021

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Nanoparticles hold great promise in tumor targeting and molecular imaging because they can co-deliver therapeutic drugs and imaging agents to the tumor site with a single entity. Nanoparticles modified with ligands against moieties overexpressed on tumor tissues have gained increasing attention due to their active targeting mechanisms. Peptides are well suited for nanoparticle targeting modifications because they are small, easy to synthesize and typically non-immunogenic. Herein, we review the peptide-modified nanoparticles used for tumor targeting therapy and molecular imaging based on the classification of peptide-targeting ligands. The development of targeting peptides and nanoparticles will also be discussed.

Keywords: Peptide, nanoparticles, neoplasm, therapeutics, molecular imaging, tumor targeting.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 22 October, 2020
Page: [6411 - 6436]
Pages: 26
DOI: 10.2174/0929867327666201022122131
Price: $65

Article Metrics

PDF: 297